fig2

Figure 2. A: the hepatocellular carcinoma (HCC) group had higher initial alanine aminotransferase (ALT) levels than HBsAg carriers without HCC (P < 0.001). The majority of HCC cases were patients who had presented with an initial ALT level around 1-2 × the upper limit of normal (ULN), while most of HBsAg carriers without HCC had presented with normal ALT levels; B: the maximal ALT level was higher in HCC cases than in HBsAg carriers without HCC (P < 0.001). Most of the HBsAg carriers without HCC had maximal ALT levels below 2 × ULN